zeneca zd 6169 has been researched along with fenoldopam in 2 studies
| Studies (zeneca zd 6169) | Trials (zeneca zd 6169) | Recent Studies (post-2010) (zeneca zd 6169) | Studies (fenoldopam) | Trials (fenoldopam) | Recent Studies (post-2010) (fenoldopam) |
|---|---|---|---|---|---|
| 42 | 0 | 3 | 657 | 92 | 94 |
| Protein | Taxonomy | zeneca zd 6169 (IC50) | fenoldopam (IC50) |
|---|---|---|---|
| D(2) dopamine receptor | Bos taurus (cattle) | 1.58 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Brott, DA; Katein, A; Lawton, M; Louden, CS; Montgomery, RR; Richardson, RJ; Thomas, H | 1 |
2 other study(ies) available for zeneca zd 6169 and fenoldopam
| Article | Year |
|---|---|
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Evaluation of von Willebrand factor and von Willebrand factor propeptide in models of vascular endothelial cell activation, perturbation, and/or injury.
Topics: Administration, Oral; Amides; Animals; Benzophenones; Biomarkers; Blood Platelets; Dogs; Dopamine; Drug-Related Side Effects and Adverse Reactions; Endothelial Cells; Female; Fenoldopam; Male; Phlebotomy; Protein Precursors; Rats; Rats, Wistar; Vascular System Injuries; von Willebrand Factor | 2014 |